Aspen Pharmacare Ltd.

30 articles about Aspen Pharmacare Ltd.

• 

  Pfizer-BioNTech Vaccine: African Deal, $34 Billion in Sales, and Efficacy Drop

  7/29/2021

  ​Pfizer has reported several highlights regarding its mRNA COVID-19 vaccine. As the world deal with rising Delta variant cases, Pfizer-BioNTech is still arguing that a third booster shot will be likely.
• 

  Mylan Acquires Aspen's European Thrombosis Portfolio for $757.3 Million

  9/8/2020

  The portfolio is made up of well-established injectable coagulants sold in Europe under various brand names, including Arixtra, Fraxiparine, Mon-Embolex and Orgaran.

• Aspen Pharmacare, Pfizer and Roche Investigated For Excessive Cancer Drug Pricing In South Africa

  6/14/2017

• Drug Giant Aspen Pharmacare Plotted to Destroy Cancer Medicine to Jack Up Prices

  4/17/2017

• Aspen Pharmacare's Old Cancer Drug Gets 1,227% Price Hike In Frugal U.K.

  1/30/2017

• Neurim Pharmaceuticals Grants Aspen Pharmacare Australia Marketing Rights For Paediatric Prolonged-Release Melatonin ("PedPRM") In Australia And New Zealand

  11/16/2016

• GlaxoSmithKline Sells Anesthetics to Aspen Pharmacare for Up to $370 Million

  9/12/2016

• Aspen Pharmacare Building China Presence For Its Generic Drug Portfolio

  7/26/2016

• Aspen Pharmacare Bags Anaesthetics Portfolio from AstraZeneca PLC in $770 Million Deal

  6/9/2016

• Starpharma Licences VivaGel BV To Aspen Pharmacare For ANZ

  3/4/2016

• Strides Arcolab Limited Ponies Up $299.90 Million for Aspen Pharmacare's Drug Brands

  5/21/2015

• Endo Pharmaceuticals Shells Out $130 Million for Nearly 70 Pipeline Programs From Aspen Pharmacare

  5/11/2015

• GlaxoSmithKline Pockets $853 Million by Halving Stake in Aspen Pharmacare

  3/13/2015

• Aspen Pharmacare Ltd. Grabs Rights to Novartis AG's Mono-Embolex for $142.3 Million

  1/23/2015

• GlaxoSmithKline Takes A 25% Stake In Aspen Pharmacare Ltd. Japanese Unit

  10/9/2014

• 42 New Jobs For Aspen Pharmacare Ltd. In Ireland

  1/23/2014

• GlaxoSmithKline To Divest One Third Of Aspen Pharmacare Ltd. Stake For $740 Million

  11/20/2013

• GlaxoSmithKline Unloads Thrombosis Brands, Manufacturing Facility to Aspen Pharmacare Ltd. for $1.13 Billion

  10/1/2013

• GlaxoSmithKline Negotiating $1 Billion Sale of Thrombosis Drugs to Aspen Pharmacare Ltd.

  6/20/2013

• S. Africa Awards $667 Million HIV Drugs Supply Contract to Abbott Laboratories, Adcock Ingram, and 10 Other Firms

  11/29/2012